The Russian pharmaceutical company Geropharm has dispatched a substantial shipment of insulin to Venezuela by sea, as confirmed by the Russian Ambassador to the Bolivarian Republic, Sergei Melik-Bagdasarov.
Last July, Geropharm shipped a batch of genetically engineered human insulin with both short and medium duration of action to Venezuela. The shipment included 1.1 million packages and syringe pens.
Melik-Bagdasarov noted that work is underway in the country to produce insulin using Russian technology. “For five years, we have been implementing a joint program with the Venezuelan Ministry of Health to supply insulin from our Russian company Geropharm, which in the future plans to launch a project here to build a production line for Venezuelan insulin using Russian technology,” he said.
